Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Surgical Oncology
Published in: Indian Journal of Surgical Oncology 2/2016

01-06-2016 | Review Article

Cytoreductive Surgery and Peritonectomy Procedures

Authors: Sanket S. Mehta, Aditi Bhatt, Olivier Glehen

Published in: Indian Journal of Surgical Oncology | Issue 2/2016

Login to get access

Abstract

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has become widely accepted as an effective method of treating peritoneal metastases (PM) from various cancers. CRS performed with the goal of removing all the macroscopic disease and comprises of peritonectomy procedures and visceral resections. CRS is a technically challenging surgery that requires a considerable amount of skill and appropriate patient selection. This article is a review of the techniques and current recommendations for performing CRS.
Literature
1.
Lambert LA (2015) Looking up: Recent advances in understanding and treating peritoneal carcinomatosis. CA Cancer J Clin 65(4):284–298CrossRefPubMed
2.
Sugarbaker PH (2015) Management of peritoneal metastases - Basic concepts. J BUON 20(Suppl 1):S2–11PubMed
3.
Healy JC, Reznek RH (1998) The peritoneum, mesenteries and omenta: normal anatomy and pathological processes. Eur Radiol 8:886–900CrossRefPubMed
4.
Meyers MA, Oliphant M, Berne AS, Feldberg MA (1987) The peritoneal ligaments and mesenteries: pathways of intraabdominal spread of disease. Radiology 163:593–604CrossRefPubMed
5.
Levy AD, Arnáiz J, Shaw JC, Sobin LH (2008) From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics 28:583–607 quiz 621-622CrossRefPubMed
6.
Sheth S, Horton KM, Garland MR, Fishman EK (2003) Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis. Radiographics 23:457–473CrossRefPubMed
7.
Oliphant M, Berne AS (1982) Computed tomography of the subperitoneal space: demonstration of direct spread of intraabdominal disease. J Comput Assist Tomogr 6:1127–1137CrossRefPubMed
8.
Karaosmanoglu D, Karcaaltincaba M, Oguz B, Akata D, Ozmen M, Akhan O (2009) CT findings of lymphoma with peritoneal, omental and mesenteric involvement: peritoneal lymphomatosis. Eur J Radiol 71:313–317CrossRefPubMed
9.
10.
11.
12.
Bao P, Bartlett D (2009) Surgical techniques in visceral resection and peritonectomy procedures. Cancer J 15(3):204–211CrossRefPubMed
13.
14.
Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH (2003) Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 22:465–472CrossRefPubMed
15.
Sugarbaker PH (2002) The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei. Eur J Surg Oncol 28:443–446CrossRefPubMed
16.
Sugarbaker P (2013) Cytoreductive surgery using peritonectomy and visceral resections for peritoneal surface malignancy. Transl Gastrointest Cancer 2(2):54–74
17.
Mohamed F, Cecil T, Moran B, Sugarbaker P (2011) A new standard of care for the management of peritoneal surface malignancy. Curr Oncol 18(2):e84–e96CrossRefPubMedPubMedCentral
18.
Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374CrossRefPubMed
19.
20.
Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJ (1997) Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anat Pathol 2:197–226PubMed
21.
Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, Lorimier G, Dubè P, Glehen O (2009) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28(1):63–68CrossRefPubMed
22.
Yan TD, Deraco M, Baratti D, et al. (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237–6242CrossRefPubMed
23.
Verwaal VJ, Kusamura S, Baratti D, et al. (2008) The eligibility for local-regional treatment of peritoneal surface malignancy. J Surg Oncol 98:220–223CrossRefPubMed
24.
Yan TD, Morris DL, Kusamura S, et al. (2008) Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Surg Oncol 98:224–227CrossRefPubMed
25.
Coakley FV, Choi PH, Gougoutas CA, et al. (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499CrossRefPubMed
26.
Esquivel J, Chua TC, Stojadinovic A, et al. (2010) Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol 102:565–570CrossRefPubMed
27.
Low RN, Barone RM, Lee MJ (2013) Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC. Ann Surg Oncol 20(4):1074–1081CrossRefPubMed
28.
Torkzad MR, Casta N, Bergman A, Ahlström H, Påhlman L, Mahteme H (2015) Comparison between MRI and CT in prediction of peritoneal carcinomatosis index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist. J Surg Oncol 111(6):746–751CrossRefPubMed
29.
Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: Enhanced CT vs. PET/CT. Abdom Imaging 33:87–89CrossRefPubMed
30.
Jacquet P, Jelinek JS, Chang D, et al. (1995) Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 181:530–538PubMed
31.
Yan TD, Haveric N, Carmignani CP, et al. (2005) Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103:839–849CrossRefPubMed
32.
Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Kluwer Academic Publishers, Boston, pp. 359–374CrossRef
33.
Goéré D, Souadka A, Faron M, Cloutier AS, Viana B, Honoré C, Dumont F, Elias D (2015) Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol 22(9):2958–2964CrossRefPubMed
34.
Coccolini F, Catena F, Glehen O, Yonemura Y, Sugarbaker PH, Piso P, Montori G, Ansaloni L (2015) Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis. Eur J Surg Oncol 41(7):911–919CrossRefPubMed
35.
Bakrin N, JM B, Decullier E, JM C, Msika S, Lorimier G, Abboud K, Meeus P, Ferron G, Quenet F, Marchal F, Gouy S, Morice P, Pomel C, Pocard M, Guyon F, Porcheron J, Glehen O, FROGHI (FRench Oncologic and Gynecologic HIPEC) Group (2013) Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39(12):1435–1443CrossRefPubMed
36.
Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, et al. (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456CrossRefPubMed
37.
Sugarbaker PH (2013) Cytoreductive surgery and perioperative chemotherapy: Textbook and video atlas. Cine-Med Publishing, Connecticut
38.
Sugarbaker PH (1999) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43:15–25CrossRef
39.
Glehen O, FN G, Arvieux C, Cotte E, Boutitie F, Mansvelt B, JM B, Lorimier G, Quenet F, Elias D, Association Française de Chirurgie (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17(9):2370–2377CrossRefPubMed
40.
Glehen O, Mohamed F, Sugarbaker PH (2004) Incomplete Cytoreduction in 174 Patients with Peritoneal Carcinomatosis From Appendiceal Malignancy. Ann Surg 240(2):278–285CrossRefPubMedPubMedCentral
41.
Dayal S, Taflampas P, Riss S, Chandrakumaran K, Cecil TD, Mohamed F, Moran BJ (2013) Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum 56(12):1366–1372CrossRefPubMed
42.
González-Moreno S, Ortega-Pérez G, González-Bayón L (2009) Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Surg Oncol 100(4):287–292CrossRefPubMed
43.
Passot G, Vaudoyer D, Cotte E, You B, Isaac S, Noël Gilly F, Mohamed F, Glehen O (2012) Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis. Ann Surg 256(1):125–129CrossRefPubMed
44.
Honoré C, Souadka A, Goéré D, Dumont F, Deschamps F, Elias D (2012) HIPEC for peritoneal carcinomatosis: does an associated urologic procedure increase morbidity? Ann Surg Oncol 19(1):104–109CrossRefPubMed
45.
Glehen O, Beaujard AC, Arvieux C, Huber O, Gilly FN (2002) Peritoneal carcinomatosis. Surgical treatment, peritonectomy and intraperitoneal chemohyperthermia. Gastroenterol Clin Biol 26:210–215PubMed
46.
Elias DM, Ouellet JF (2001) Intraperitoneal chemohyperthermia: rationale, technique, indications, and results. Surg Oncol Clin N Am 10:915–933PubMed
47.
Elias D, Benizri E, Pocard M, Ducreux M, Boige V, Lasser P (2006) Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 32:632–636CrossRefPubMed
48.
Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B, Hay JM, Flamant Y, Msika S (2007) Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 245:597–603CrossRefPubMedPubMedCentral
49.
Cotte E, Passot G, Gilly F-N, Glehen O (2010) Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol 2(1):31–35CrossRefPubMedPubMedCentral
50.
51.
52.
Zappa L, Sugarbaker PH (2007) Compartment syndrome of the leg associated with lithotomy position for cytoreductive surgery. J Surg Oncol 96:619–623CrossRefPubMed
53.
de Lima VV, Sugarbaker PH (2003) Xiphoidectomy. Gastric Cancer 6:127–129
54.
Vazquez Vde L, Sugarbaker PH (2003) Total anterior parietal peritonectomy. J Surg Oncol 83:261–263CrossRefPubMed
55.
Dagbert F, Passot G, Glehen O, Bakrin N (2015) Glisson capsulectomy for extensive superficial liver involvement in peritoneal carcinomatosis (with video). J Visc Surg 152(5):332–333CrossRefPubMed
56.
Deslauriers N, Olney H, Younan R (2011) Splenectomy revisited in 2011: Impact on hematologic toxicities while performing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Gastrointest Oncol 2(2):61–63PubMedPubMedCentral
57.
Becher RD, Shen P, Stewart JH, Russell G, Bradley JF, Levine EA (2011) Splenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy. J Gastrointest Oncol 2(2):70–76PubMedPubMedCentral
58.
Sugarbaker PH (2010) Pont hepatique (hepatic bridge), an important anatomic structure in cytoreductive surgery. J Surg Oncol 101:251–252CrossRefPubMed
59.
60.
Bijelic L, Sugarbaker PH (2008) Cytoreduction of the small bowel surfaces. J Surg Oncol 97:176–179CrossRefPubMed
61.
Pathiraja PNJ, Garruto-Campanile R, Tozzi R (2013) Diaphragmatic Diaphragmatic peritonectomy versus full thickness diaphragmatic resection and pleurectomy during cytoreduction in patients with ovarian cancer. Int J Surg Oncol 2013:876150PubMedPubMedCentral
62.
Hertel H, Diebolder H, Herrmann J, Köhler C, Kühne-Heid R, Possover M, Schneider A (2001) Is the decision for colorectal resection justified by histopathologic findings: a prospective study of 100 patients with advanced ovarian cancer. Gynecol Oncol; 83(3):481–484. PMID:11733959
63.
Obermair A, Hagenauer S, Tamandl D, Clayton RD, Nicklin JL, Perrin LC, Ward BG, Crandon AJ (2001) Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 83(1):115–120CrossRefPubMed
64.
Yildirim Y, Ertas IE, Nayki U, Ulug P, Nayki C, Yilmaz I, Gultekin E, Dogan A, Aykas A, Ulug S, Ozdemir A, Solmaz U (2014) En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer. Eur J Gynaecol Oncol 35(4):400–407PubMed
65.
Mourton SM, Temple LK, Abu-Rustum NR, Gemignani ML, Sonoda Y, Bochner BH, Barakat RR, Chi DS (2005) Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 99(3):608–614CrossRefPubMed
66.
Sonnendecker EW, Beale PG (1989) Rectosigmoid resection without colostomy during primary cytoreductive surgery for ovarian carcinoma. Int Surg 74(1):10–12PubMed
67.
Sugarbaker PH (2015) Avoiding Diverting Ileostomy in Patients Requiring Complete Pelvic Peritonectomy. Ann Surg Oncol 2015
68.
Sugarbaker PH (2002) Cytoreduction including total gastrectomy for pseudomyxoma peritonei. Br J Surg 89(2):208–212CrossRefPubMed
69.
Piso P, Slowik P, Popp F, Dahlke MH, Glockzin G, Schlitt HJ (2009) Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 16(8):2188–2194CrossRefPubMed
70.
Deraco M, Baratti D, Kusamura S, Laterza B, Balestra MR (2009) Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol 100(4):321–328. doi:10.​1002/​jso.​21388 CrossRefPubMed
71.
Foster JM, Gupta PK, Carreau JH, Grotz TE, Blas JV, Gatalica Z, Nath S, Loggie BW (2012) Right hemicolectomy is not routinely indicated in pseudomyxoma peritonei. Am Surg 78(2):171–177PubMed
72.
Doud AN, Randle RW, Clark CJ, Levine EA, Swett KR, Shen P, Stewart JH, Votanopoulos KI (2015) Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2(5):1645–1650CrossRef
73.
Schwarz L, Votanopoulos K, Morris D, Yonemura Y, Deraco M, Piso P, Moran B, Levine EA, Tuech JJ (2016) Is the Combination of Distal Pancreatectomy and Cytoreductive Surgery With HIPEC Reasonable?: Results of an International Multicenter Study. Ann Surg 263(2):369–375CrossRefPubMed
74.
Mahdi H, Rose PG, Gonzalez S, DeBernardo R, Knight J, Michener C, Moselmi-Kebria M (2015) Postoperative Complications After Distal Pancreatectomy Performed During Cytoreductive Surgery for Gynecologic Malignancies. Int J Gynecol Cancer 25(6):1128–1133CrossRefPubMed
75.
Bacalbasa N, Dima S, Brasoveanu VDavid L, et al. (2015) Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit. World J Surg Oncol 13:235CrossRefPubMedPubMedCentral
76.
Gasparri ML, Grandi G, Bolla D, Gloor B, Imboden S, Panici PB, Mueller MD, Papadia A (2015) Hepatic resection during cytoreductive surgery for primary or recurrent ovarian cancer. J Cancer Res Clin Oncol 1–12
77.
Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, et al. (2003) Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863–869CrossRefPubMed
78.
Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FAN (2004) Toxicity of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 85:61–67CrossRefPubMed
79.
Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, et al. (2006) Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 106:1144–1153CrossRefPubMed
80.
Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, et al. (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6:790–796CrossRefPubMed
81.
Franko J, Gusani NJ, Holtzman MP, Ahrendt SA, Jones HL, HJ Z 3rd, DL B (2008) Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol 15(11):3065–3072CrossRefPubMed
Metadata
Title
Cytoreductive Surgery and Peritonectomy Procedures
Authors
Sanket S. Mehta
Aditi Bhatt
Olivier Glehen
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 2/2016
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-016-0505-5

Other articles of this Issue 2/2016

Indian Journal of Surgical Oncology 2/2016 Go to the issue

Editorial Notes

Peritoneal Metastases: Prevention and Treatment

Review Article

The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review

Review Article

Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies

Review Article

Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal Cancer

Review Article

Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Preface

Preface